Welcome to AZ MedX

AstraZeneca’s Respiratory & Immunology medical resource centre for healthcare professionals

Discover the latest advances and approaches in asthma, COPD and more

This site is intended for the use of Healthcare Professionals only. By clicking the link below you declare and confirm:

If you are not a Healthcare Professional, please follow this link for information on global patient resources.

SABA Reliever Over-Reliance

Many people with asthma tend to over-rely on their short-acting β2-agonist (SABA) inhaler [1,2]. Although SABAs provide quick relief of symptoms, overuse can increase the risk of exacerbations [3].

The Blue Reliever Reliance Test – featuring a simple, five-item, evidence-based questionnaire – can support you to assess SABA over-reliance with your patients and explore their asthma management needs.

Try the blue reliever reliance test for yourself

Are your asthma patients over-reliant on their SABA inhalers?

You are now leaving: http://azmedx.com/

By following this link you will be leaving the AZ MedX website.

Please note that AstraZeneca does not take responsibility for the content displayed on other websites.

Continue Return to AZ MedX